Magnus Rasmussen
16 – 30 of 156
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Treatment refractory arthritis and stroke – A case of infective endocarditis caused by Tropheryma whipplei
(
- Contribution to journal › Article
-
Mark
Fatal infective endocarditis caused by Aerococcus sanguinicola : a case report and literature review
(
- Contribution to journal › Article
-
Mark
Time to positivity of blood cultures in bloodstream infections with Streptococcus dysgalactiae and association with outcome
(
- Contribution to journal › Article
-
Mark
Microorganisms that commonly cause infective endocarditis- what about Aerococcus in the Duke-ISCVID criteria?
2023) In Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 77(8). p.1217-1219(
- Contribution to journal › Letter
-
Mark
S taphylococcus aureus bacteraemia, cardiac implantable electronic device, and the risk of endocarditis : a retrospective population–based cohort study
(
- Contribution to journal › Article
- 2022
-
Mark
Blood culture time to positivity in non-β-hemolytic streptococcal bacteremia as a predictor of infective endocarditis-a retrospective cohort study
(
- Contribution to journal › Article
-
Mark
High level of protection against COVID-19 after two doses of BNT162b2 vaccine in the working age population–first results from a cohort study in Southern Sweden
(
- Contribution to journal › Article
-
Mark
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line
(
- Contribution to journal › Article
-
Mark
Risk stratification score screening for infective endocarditis in patients with Gram-positive bacteraemia
(
- Contribution to journal › Article
-
Mark
Microbiological etiology in prosthetic valve endocarditis : A nationwide registry study
(
- Contribution to journal › Article
-
Mark
COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022
2022) In Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 27(18).(
- Contribution to journal › Article
-
Mark
One Scoring System Does Not Fit All Healthcare Settings
2022) In Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 74(1). p.166-167(
- Contribution to journal › Letter
-
Mark
Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2
(
- Contribution to journal › Article
-
Mark
Streptococcus bovis-bacteremia: subspecies distribution and association with colorectal cancer : a retrospective cohort study
(
- Contribution to journal › Article
-
Mark
Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases
(
- Contribution to journal › Article